BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10079682)

  • 1. Ticlopidine-induced thrombocytopenia.
    Koornstra JJ; Loualidi A; de Vries CJ
    Neth J Med; 1999 Feb; 54(2):73-5. PubMed ID: 10079682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatal neutropenia and thrombocytopenia associated with ticlopidine after stenting.
    Szto GY; Linnemeier TJ; Ball MW
    Am J Cardiol; 1999 Jan; 83(1):138-9, A10. PubMed ID: 10073806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clopidogrel and thrombopenia. A case report].
    Helft G; Elalamy I; Laudy C; Tran D; Beygui F; Le Feuvre C; Ounissi F; Monnet de Lorbeau B; Khellaf C; Metzger JP
    Ann Cardiol Angeiol (Paris); 2003 Jun; 52(3):191-3. PubMed ID: 12938574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bone marrow aplasia associated to the use of ticlopidine].
    Ruiz C; Monroy T; Montaña N; Lora P; Lamich R; Valderrama A
    Rev Med Chil; 2002 Jul; 130(7):798-802. PubMed ID: 12235906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse haematological effects of ticlopidine. Prevention, recognition and management.
    Love BB; Biller J; Gent M
    Drug Saf; 1998 Aug; 19(2):89-98. PubMed ID: 9704247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombocytopenia induced by both aspirin and clopidogrel in the same patient.
    Hu Y; Yuan M; Lu X
    Int J Clin Pharmacol Ther; 2013 Mar; 51(3):228-31. PubMed ID: 23357845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bone marrow aplasia related to ticlopidine].
    de Jaureguiberry JP; Galzin M; Talard P; Marlier S; Durupt S; Bouchiat C; Dussarat GV; Jaubert D
    Rev Med Interne; 1996; 17(12):1032-6. PubMed ID: 9008753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of glycoprotein IIb-IIIa receptor antagonism on platelet membrane glycoproteins after coronary stent placement.
    Gawaz M; Ruf A; Neumann FJ; Pogátsa-Murray G; Dickfeld T; Zohlnhöfer D; Schömig A
    Thromb Haemost; 1998 Dec; 80(6):994-1001. PubMed ID: 9869173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ticlopidine-induced neutropenia mimicking sepsis early after intracoronary stent placement.
    Ochoa AB; Wolfe M; Lewis P; Lenihan DJ
    Clin Cardiol; 1998 Apr; 21(4):304-7. PubMed ID: 9562945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombocytopenia and hepatitis complicating ticlopidine therapy.
    Friedman ND; Sitlington R; Lodge RS
    Aust N Z J Med; 1997 Oct; 27(5):599. PubMed ID: 9404597
    [No Abstract]   [Full Text] [Related]  

  • 11. Usefulness of cilostazol versus ticlopidine in coronary artery stenting.
    Yoon Y; Shim WH; Lee DH; Pyun WB; Kim IJ; Jang Y; Cho SY
    Am J Cardiol; 1999 Dec; 84(12):1375-80. PubMed ID: 10606107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ticlopidine-induced aplastic anemia and quick recovery with G-CSF: case report and literature review.
    Taher A; Ammash Z; Dabajah B; Nasrallah A; Mourad FH
    Am J Hematol; 2000 Feb; 63(2):90-3. PubMed ID: 10629575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute profound thrombocytopenia following angioplasty: the dilemma in the management and a review of the literature.
    Makoni SN
    Heart; 2001 Dec; 86(6):E18. PubMed ID: 11711483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolated profound thrombocytopenia associated with clopidogrel.
    Elmi F; Peacock T; Schiavone J
    J Invasive Cardiol; 2000 Oct; 12(10):532-5. PubMed ID: 11022215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ticlopidine-associated pancytopenia: implications of an acetylsalicylic acid alternative.
    Gill S; Majumdar S; Brown NE; Armstrong PW
    Can J Cardiol; 1997 Oct; 13(10):909-13. PubMed ID: 9374946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombocytopenia and glycoprotein IIb-IIIa receptor antagonists.
    Stiegler HM; Fischer Y; Steiner S
    Lancet; 1999 Apr; 353(9159):1185. PubMed ID: 10210005
    [No Abstract]   [Full Text] [Related]  

  • 17. Incidence and clinical course of thrombotic thrombocytopenic purpura due to ticlopidine following coronary stenting. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting.
    Steinhubl SR; Tan WA; Foody JM; Topol EJ
    JAMA; 1999 Mar; 281(9):806-10. PubMed ID: 10071001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ticlopidine-induced aplastic anemia: two new case reports, review, and meta-analysis of 55 additional cases.
    Symeonidis A; Kouraklis-Symeonidis A; Seimeni U; Galani A; Giannakoulas N; Fragopanagou E; Tiniakou M; Matsouka P; Zoumbos N
    Am J Hematol; 2002 Sep; 71(1):24-32. PubMed ID: 12221670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ticlopidine-induced severe agranulocytosis after the placement of coronary artery stent--a case report.
    Sari R; Sevinc A; Buyukberber S
    Angiology; 2000 Jul; 51(7):591-3. PubMed ID: 10917583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe aplastic anemia induced by ticlopidine: report of a case.
    Su CC; Tseng CD; Hwang JJ; Tien HF; Lee YT
    J Formos Med Assoc; 1995 Nov; 94(11):689-91. PubMed ID: 8527978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.